Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Titel:
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Auteur:
Azad, Arun A Bressel, Mathias Tan, Hsiang Voskoboynik, Mark Suder, Aneta Weickhardt, Andrew J Guminski, Alexander Francis, Roslyn J Saghebi, Javad Dhiantravan, Nattakorn Joshua, Anthony M Emmett, Louise Horvath, Lisa Murphy, Declan G Hsiao, Edward Balakrishnar, Bavanthi Lin, Peter Redfern, Andrew Macdonald, William Ng, Siobhan Lee, Sze-Ting Pattison, David A Nadebaum, David Kirkwood, Ian D Hofman, Michael S